What Are the Challenges in Developing Nano Vaccines?
Despite their potential, there are several challenges in developing nano vaccines:
Safety Concerns: The long-term safety of nanoparticles in the human body is still being studied, and there are concerns about potential toxicity. Manufacturing Complexity: Producing nanoparticles consistently and at scale can be technically challenging and expensive. Regulatory Hurdles: New technologies face rigorous regulatory scrutiny, and nano vaccines are no exception. Demonstrating safety and efficacy to regulatory bodies can be a lengthy process. Stability Issues: While nanoparticles can enhance antigen stability, ensuring the stability of the nanoparticles themselves can be difficult.
